Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of panobinostat in advanced small cell lung cancer
2007-007139-26Phase 2Completed
- Sponsor
- Sendo
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panobinostat in small cell lung cancer (SCLC), sponsored by Sendo. Primary endpoint: Objective response rate. Started Apr 2008; status: completed.
02
Drugs
panobinostat
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2007-007139-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007139-26.